Prednisolone Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg, 20 mg, 50 mg
Reference Brands: Generics & generic brands available in EU &US
Category:
Transplant
Prednisolone is an anti-inflammatory corticosteroid that suppresses immune responses by inhibiting multiple pathways, reducing swelling, redness, and allergic reactions. It effectively treats autoimmune diseases, allergies, and inflammatory conditions. Benefits include symptom relief, decreased inflammation, improved organ function, and enhanced quality of life, especially in chronic autoimmune and allergic disorders
Prednisolone tablets is available in Tablets
and strengths such as 5 mg, 20 mg, 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Prednisolone tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Prednisolone tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Prednisolone tablets, marketed as various generic brands, are approved in the US by the FDA and in the EU via EMA for treating inflammation, allergies, and autoimmune disorders. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety, efficacy, and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regulatory adherence supports swift approval, safe usage, and global availability of prednisolone tablets, supporting effective management of inflammatory and autoimmune conditions worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing